This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Metastatic Pancreatic Cancer
and you are
over 18
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to test the safety, activity and best doses of FOLFOX-A which consists of the standard chemotherapy drugs fluorouracil, leucovorin, oxaliplatin and abraxane. Each of these drugs are currently used in pancreatic cancer. The experimental part of the study is combining these drugs together in FOLFOX-A.

Provided treatments

  • Drug: Dose level 1
  • Drug: Dose level 2/MTD
  • Drug: Dose level 3

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01744353. The sponsor of the trial is Brown University and it is looking for 35 volunteers for the current phase.
Official trial title:
BrUOG 278:FOLFOX-A For Pancreatic Cancer :A Brown University Oncology Research Group Study